Call for Information (Investigational Site 0004)

New Haven, Connecticut 06513

0 studies enrolling now · 1 studies all time

What they study most

Bladder Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Ovarian Cancer

Studies at this site

• Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) — Stopped early